Characterization of Next-Generation Inhibitors for the Inward-Rectifier Potassium Channel Kir2.1: Discovery of VU6080824.

Saved in:
Bibliographic Details
Title: Characterization of Next-Generation Inhibitors for the Inward-Rectifier Potassium Channel Kir2.1: Discovery of VU6080824.
Authors: Duncan RA; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Haymer DH; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Lazarenko RM; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States., Li L; VVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States., Blackwell Y; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States., Days EL; VVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States., Krishnan S; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Gray AT; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Boutaud O; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Engers DW; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States., Lindsley CW; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee 37205, United States., Denton JS; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.; VVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States., Bender AM; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2025 Aug 29; Vol. 16 (9), pp. 1762-1771. Date of Electronic Publication: 2025 Aug 29 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1948-5875
DOI:10.1021/acsmedchemlett.5c00297